FIT programmesPositivity cut-offScreeneesPositive testsColonoscopy assessment
μg. Hb/g. faecesNN%Performed (N)% Compliance% Completed
Belgium Flemish region, women15164.00010.5606.400.098,3
Belgium Flemish region, men15153.52015.31310.000.098,8
Belgium Flemish region, all15317.52025.8738.100.098,5
Czech Republic, women15290.56118.0586.29.65453.595,5
Czech Republic, men15204.75818.0818.89.83354.497,5
Czech Republic, all15495.31936.1397.319.48753.994,8
France Calvados, women18013.4553942.934788.193,1
France Calvados, men18010.1533823.833487.494,3
France Calvados, all18023.6087763.368187.893,7
Hungary, women204.4503187.120564.5NA
Hungary, men203.41645113.228964.1NA
Hungary, all207.8667699.849464.2NA
Ireland, all2023.5111.8988.11.35271.296,1
Italy, women201.062.73843.6414.133.47276.790,9
Italy, men20906.79351.0845.640.00378.393,8
Italy, all201.969.53194.7254.873.47577.692,4
Lithuania, womenNA146.0878.4595.84.35651.5NA
Lithuania, menNA88.1708.5949.74.02746.9NA
Lithuania, allNA234.25717.0537.38.38349.2NA
Malta, all16–20*+6.7542904.319266.2NA
Netherlands, women†15–47‡269.77916.6216.212.80977.1NA
Netherlands, men†15–47‡254.35624.2219.518.95078.2NA
Netherlands, all†15–47‡524.13540.8427.831.75977.8NA
Slovenia, women20 (2 samples)138.7036.5484.76.07692.898,4
Slovenia, men20 (2 samples)113.2458.5997.67.89391.899,0
Slovenia, all20 (2 samples)251.94815.1476.013.96992.298,8
Spain, women20241.52912.6355.211.51391.191,9
Spain, men20207.43017.3668.415.69490.493,4
Spain, all20448.95930.0016.727.20790.792,8
  • *Borderline cases retested.

  • †The Dutch data have been published in a paper presenting the results of the first year of screening activity.19

  • ‡The positivity cut-off had been changed during the reference year.

  • FIT, faecal immunochemical test; gFOBT, guaiac faecal occult blood test.